Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the VERSAJET™ device with conventional surgical procedures (performed with a scalpel) in the debridement (removal of unhealthy tissue) of lower limb ulcers.
It is hypothesised that the time taken to debride lower limb ulcers will be quicker with the VERSAJET™ device than with conventional surgical procedures.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetic Foot Varicose Ulcer Pressure Ulcer |
Device: Versajet Hydrosurgery System Procedure: Conventional surgical debridement techniques |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Prospective, Comparative, Single-Centre Clinical Evaluation to Investigate the Skin-to-Skin Time of the First Surgical Debridement of Lower Extremity Ulcers With VERSAJET™ Hydrosurgery System and Conventional Debridement Techniques. |
- Reduction in the average skin-to-skin time of the first surgical debridement with VERSAJET™, compared to conventional debridement techniques. [ Time Frame: During surgery ]
- Difference in the total average time of the debridement procedure, including preparation, skin-to-skin and recovery, according to the debridement technique. [ Time Frame: Entry into OR holding area to discharge from recovery room ]
- Difference in outcomes of the procedure, according to the debridement technique in terms of; time to wound closure, number of subsequent debridements, number of serious adverse events [ Time Frame: 3 months post-op ]
| Enrollment: | 46 |
| Study Start Date: | April 2006 |
| Study Completion Date: | September 2006 |
| Arms | Assigned Interventions |
|---|---|
|
Treatment
Debridement with Versajet Hydrosurgery system
|
Device: Versajet Hydrosurgery System
Debridement with Versajet Hydrosurgery System
|
|
Control
Conventional surgical debridement techniques
|
Procedure: Conventional surgical debridement techniques
Conventional surgical debridement with scalpel and pulse lavage
|
Detailed Description:
This is prospective, comparative clinical evaluation to investigate whether there is a reduction in the skin-to-skin time of the first surgical debridement with VERSAJET™, compared to conventional debridement techniques. Skin-to-skin time is defined as the time of incision to the end time of debridement (wound ready for dressing application). Conventional debridement is defined as scalpel plus pulse lavage.
The purpose of this comparison is to demonstrate the resource savings which VERSAJET™ may provide in terms of operating room (OR) and personnel time, in addition to the potential to reduce the procedure, and possibly anaesthetic, time for the patient. It is envisaged that this information, combined with the costs associated with the procedure, will also provide valuable economic data to help justify the use of VERSAJET™ from a financial perspective and support the future commercial success of the device.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who are at least 18 years of age.
- Males and females (provided they are not pregnant or, if of reproductive age, are using contraception).
- Patients with a venous stasis, diabetic foot or decubitus reference ulcer located between the tibia and foot.
- Patients undergoing surgical debridement of their reference ulcer in the operating room (OR).
- Patients undergoing their first surgical debridement of the reference ulcer.
- Patients suitable for debridement of their reference ulcer with both VERSAJET™ and conventional debridement techniques.
- Patients who are able to understand the evaluation and are willing and able to provide written consent to participate in the evaluation.
Exclusion Criteria:
- Patients with clinical signs of infection in the reference ulcer (e.g. purulence and / or odour).
- Patients with haemophilia
- Patients who have been treated with topical steroids, systemic immunosuppressants (including corticosteroids), anticoagulants or cytotoxic chemotherapy in the last 30 days, or who are anticipated to require such medications during the course of the study.
- Patients known to have Acquired Immunodeficiency Syndrome (AIDS) or known to be infected with Human Immunodeficiency Virus (HIV).
- Patients who suffer from acute or chronic bacterial, viral or fungal skin diseases that would interfere with wound healing.
- Patients with a known history of poor compliance with medical treatment.
- Patients who have participated in this evaluation previously or are currently participating in another clinical study.
Contacts and Locations| United States, New Jersey | |
| Clara Maass Medical Center | |
| Belleville, New Jersey, United States, 07109 | |
| Principal Investigator: | Wayne J Caputo, DPM | Clara Maass Medical Center |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00521027 History of Changes |
| Other Study ID Numbers: | CE025VJT |
| Study First Received: | August 23, 2007 |
| Last Updated: | August 23, 2007 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Smith & Nephew Medical Ltd:
|
Debridement hydrosurgery Versajet leg ulcer |
Additional relevant MeSH terms:
|
Pressure Ulcer Ulcer Varicose Ulcer Diabetic Foot Skin Ulcer Skin Diseases Pathologic Processes Varicose Veins Vascular Diseases |
Cardiovascular Diseases Leg Ulcer Diabetic Angiopathies Foot Ulcer Diabetes Complications Diabetes Mellitus Endocrine System Diseases Diabetic Neuropathies |
ClinicalTrials.gov processed this record on May 23, 2013